Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Drotaverine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Drotaverine: Patents, clinical trial progress, indications

Drotaverine is an investigational drug.

There have been 6 clinical trials for Drotaverine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2005.

The most common disease conditions in clinical trials are Pancreatic Diseases, Bile Duct Diseases, and Renal Colic. The leading clinical trial sponsors are Ain Shams University, Changhai Hospital, and Sanofi.

Recent Clinical Trials for Drotaverine
Morphine Versus Ketorolac in Renal ColicLoredana GhineaPhase 4
The Impact of Papaverine on First Stage of Laboreran ashwalPhase 3
Drotaverine to Shorten the Length of LaborAin Shams Maternity HospitalPhase 2/Phase 3

See all Drotaverine clinical trials

Clinical Trial Summary for Drotaverine

Top disease conditions for Drotaverine
Top clinical trial sponsors for Drotaverine

See all Drotaverine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.